Company News
March 20, 2018 / 12:38 AM / a year ago

BRIEF-Helix Biopharma Reports Q2 Loss Per Share of C$0.03

1 Min Read

March 19 (Reuters) - Helix Biopharma Corp:

* . ANNOUNCES FISCAL SECOND QUARTER 2018 RESULTS

* Q2 LOSS PER SHARE C$0.03 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below